Survivin Small Molecules Inhibitors: Recent Advances and Challenges
Molecules · 01.02.2023 · 28 (3) · 1376
DOI: 10.3390/molecules28031376 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 01.02.2023. Verfasst von Najah Albadari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute.
Abstract (Originalsprache)
Survivin, as a member of the inhibitor of apoptosis proteins (IAPs) family, acts as a suppressor of apoptosis and plays a central role in cell division. Survivin has been considered as an important cancer drug target because it is highly expressed in many types of human cancers, while it is effectively absent from terminally differentiated normal tissues. Moreover, survivin is involved in tumor cell resistance to chemotherapy and radiation. Preclinically, downregulation of survivin expression or function reduced tumor growth induced apoptosis and sensitized tumor cells to radiation and chemotherapy in different human tumor models. This review highlights the role of survivin in promoting cellular proliferation and inhibiting apoptosis and summarizes the recent advances in and challenges of developing small-molecule survivin inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
ORCID-Profile: Wei Li
Förderung
- National Cancer Institute
Zitieren
APA
Albadari, N., & Li, W. (2023). Survivin Small Molecules Inhibitors: Recent Advances and Challenges. Molecules, 28(3), 1376. https://doi.org/10.3390/molecules28031376
Vancouver
Albadari N, Li W. Survivin Small Molecules Inhibitors: Recent Advances and Challenges. Molecules. 2023;28(3):1376. doi:10.3390/molecules28031376
BibTeX
@article{Albadari2023,
author = {Albadari, Najah and Li, Wei},
title = {Survivin Small Molecules Inhibitors: Recent Advances and Challenges},
journal = {Molecules},
year = {2023},
volume = {28},
number = {3},
pages = {1376},
doi = {10.3390/molecules28031376}
}
EUVIMED